Anesthesia, ICU & Pain Management, Hamad General Hospital, Doha, Qatar.
Libyan J Med. 2011;6. doi: 10.3402/ljm.v6i0.7041. Epub 2011 Jul 14.
Succinylcholine remains the drug of choice for satisfactory rapid-sequence tracheal intubation. It is not clear from the literature why the 1 mg/kg dose of succinylcholine has been traditionally used. The effective dose (ED95) of succinylcholine is less than 0.3 mg/kg. The dose of 1 mg/kg represents 3.5 to 4 times the ED(95).
To compare the effect of the traditionally used 1 mg/kg of succinylcholine with lower doses of 0.6 mg/kg and 0.45 mg/kg on intubation condition regarding the onset time, duration of action, duration of abdominal fasciculation, and the intubation grading.
This retrospective comparative study was carried into three groups of ASA III & IV (American Society of Anesthesiologist's Physical Status III and IV) non-prepared emergency patients who were intubated at emergency department of Hamad General Hospital, Doha, Qatar during January 1st 2007 to August 31, 2010. The Institutional Research Board (IRB) approval was obtained. This study was limited to 88 patients who received fentanyl 1µg/kg followed by etomidate 0.3 mg/kg intravenously as induction agents and succinylcholine as a muscle relaxant agent in doses of 0.45 mg/kg, 0.6 mg/kg, or 1 mg/kg.
Increasing the succinylcholine dosage shortened the onset time, prolonged the duration of action, and prolonged the duration of abdominal fasciculation significantly (P<.001). Tracheal intubation was 100% successful in the three groups of patients.
Succinylcholine dose of 0.45 mg/kg provides an optimal intubation condition in ASA III & IV emergency non-prepared patients. Duration of action of succinylcholine is dose dependent; reducing the dose allows a more rapid return of spontaneous respiration and airway reflexes.
琥珀酰胆碱仍然是满足快速序贯气管插管的首选药物。文献中不清楚为什么传统上使用 1 毫克/千克剂量的琥珀酰胆碱。琥珀酰胆碱的有效剂量(ED95)小于 0.3 毫克/千克。1 毫克/千克的剂量代表 ED(95)的 3.5 到 4 倍。
比较传统使用的 1 毫克/千克琥珀酰胆碱与 0.6 毫克/千克和 0.45 毫克/千克较低剂量对插管条件的影响,包括起效时间、作用持续时间、腹部束颤持续时间和插管分级。
这是一项回顾性比较研究,纳入了在卡塔尔多哈的哈马德总医院急诊科接受插管的 ASA III 和 IV 级(美国麻醉医师协会身体状况 III 和 IV 级)未准备好的急诊患者,纳入时间为 2007 年 1 月 1 日至 2010 年 8 月 31 日。获得了机构研究委员会(IRB)的批准。本研究仅限于 88 名接受 1μg/kg 芬太尼和 0.3mg/kg 依托咪酯静脉诱导后接受 0.45mg/kg、0.6mg/kg 或 1mg/kg 琥珀酰胆碱的患者。
增加琥珀酰胆碱剂量可显著缩短起效时间、延长作用持续时间和延长腹部束颤持续时间(P<.001)。三组患者的气管插管均 100%成功。
在 ASA III 和 IV 级未准备好的急诊患者中,琥珀酰胆碱 0.45mg/kg 剂量可提供最佳插管条件。琥珀酰胆碱的作用持续时间与剂量相关;降低剂量可使自主呼吸和气道反射更快恢复。